Inmaculada Heras

2.0k total citations · 1 hit paper
44 papers, 962 citations indexed

About

Inmaculada Heras is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Inmaculada Heras has authored 44 papers receiving a total of 962 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 13 papers in Oncology and 13 papers in Immunology. Recurrent topics in Inmaculada Heras's work include Hematopoietic Stem Cell Transplantation (21 papers), Lymphoma Diagnosis and Treatment (10 papers) and Acute Lymphoblastic Leukemia research (8 papers). Inmaculada Heras is often cited by papers focused on Hematopoietic Stem Cell Transplantation (21 papers), Lymphoma Diagnosis and Treatment (10 papers) and Acute Lymphoblastic Leukemia research (8 papers). Inmaculada Heras collaborates with scholars based in Spain, Italy and Montserrat. Inmaculada Heras's co-authors include Vicente Vicente, Marı́a Luisa Lozano, Josep‐María Ribera, Mar Tormo, Javier Corral, Rocío Gónzález‐Conejero, Javier Bueno, Albert Oriol, Pilar Bastida and Eloy del Potro and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Nature reviews. Cancer.

In The Last Decade

Inmaculada Heras

43 papers receiving 939 citations

Hit Papers

Cross-priming in cancer immunology and immunotherapy 2025 2026 2025 10 20 30
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cross-priming in cancer immunology and immunotherapy
    2025 33 citations Carlos Luri‐Rey, Álvaro Teijeira et al. Nature reviews. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inmaculada Heras Spain 17 494 288 281 201 175 44 962
Keiko Yumura‐Yagi Japan 18 605 1.2× 383 1.3× 332 1.2× 243 1.2× 150 0.9× 49 1.2k
Alexey Maschan Russia 17 477 1.0× 211 0.7× 236 0.8× 80 0.4× 85 0.5× 137 854
Yukiko Tsunematsu Japan 22 425 0.9× 158 0.5× 208 0.7× 104 0.5× 101 0.6× 61 1.2k
Reggie Duerst United States 17 414 0.8× 168 0.6× 213 0.8× 91 0.5× 132 0.8× 42 902
John Moppett United Kingdom 19 397 0.8× 482 1.7× 230 0.8× 83 0.4× 255 1.5× 46 925
Masaaki Kumagai Japan 12 242 0.5× 301 1.0× 164 0.6× 125 0.6× 156 0.9× 28 633
Guillermo Debén Spain 15 720 1.5× 304 1.1× 244 0.9× 258 1.3× 82 0.5× 35 1.3k
Roberta H. Adams United States 15 371 0.8× 118 0.4× 172 0.6× 63 0.3× 100 0.6× 53 818
Massimiliano Postorino Italy 16 626 1.3× 263 0.9× 143 0.5× 109 0.5× 41 0.2× 39 924
Yasunori Ueda Japan 20 1.1k 2.3× 699 2.4× 410 1.5× 174 0.9× 108 0.6× 115 1.6k

Countries citing papers authored by Inmaculada Heras

Since Specialization
Citations

This map shows the geographic impact of Inmaculada Heras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inmaculada Heras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inmaculada Heras more than expected).

Fields of papers citing papers by Inmaculada Heras

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inmaculada Heras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inmaculada Heras. The network helps show where Inmaculada Heras may publish in the future.

Co-authorship network of co-authors of Inmaculada Heras

This figure shows the co-authorship network connecting the top 25 collaborators of Inmaculada Heras. A scholar is included among the top collaborators of Inmaculada Heras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inmaculada Heras. Inmaculada Heras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luri‐Rey, Carlos, Álvaro Teijeira, Stefanie K. Wculek, et al.. (2025). Cross-priming in cancer immunology and immunotherapy. Nature reviews. Cancer. 25(4). 249–273. 33 indexed citations breakdown →
2.
Bravo‐Pérez, Carlos, José Padilla, María Eugenia de la Morena‐Barrio, et al.. (2024). The whole is greater than the sum of its parts: Long‐read sequencing for solving clinical problems in haematology. Journal of Cellular and Molecular Medicine. 28(3). e17961–e17961. 2 indexed citations
3.
Mora, Elvira, Juan Montoro, Aitana Balaguer‐Roselló, et al.. (2024). Total body irradiation versus thiotepa/busulfan-based conditioning regimens for myeloablative allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia. Bone Marrow Transplantation. 59(8). 1137–1145. 1 indexed citations
4.
Martı́nez, Carmen, Cecilia Carpio, Inmaculada Heras, et al.. (2020). Potential Survival Benefit for Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation after Nivolumab Therapy for Relapse/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain. Biology of Blood and Marrow Transplantation. 26(8). 1534–1542. 18 indexed citations
5.
Gayoso, Jorge, Pascual Balsalobre, María‐Jesús Pascual, et al.. (2016). Busulfan-based reduced intensity conditioning regimens for haploidentical transplantation in relapsed/refractory Hodgkin lymphoma: Spanish multicenter experience. Bone Marrow Transplantation. 51(10). 1307–1312. 20 indexed citations
6.
7.
Fox, María Laura, Pere Barba, Inmaculada Heras, et al.. (2014). A registry-based study of non-Aspergillus mould infections in recipients of allogeneic haematopoietic cell transplantation. Clinical Microbiology and Infection. 21(1). e1–e3. 11 indexed citations
8.
Ferrá, Christelle, Jaime Sanz, Miguel Ángel Díaz, et al.. (2014). Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients. Leukemia & lymphoma. 56(3). 656–662. 33 indexed citations
9.
Díaz‐Beyá, Marina, Salut Brunet, Josep Nomdedéu, et al.. (2013). MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemia. Leukemia. 28(4). 804–812. 47 indexed citations
10.
Llorente, Andreu, Ignacio Valero, Inmaculada Heras, et al.. (2011). Mortality risk factors in patients with zygomycosis: a retrospective and multicentre study of 25 cases. Enfermedades Infecciosas y Microbiología Clínica. 29(4). 263–268. 8 indexed citations
11.
Martı́n, Alejandro, E. Condé, Antonio Pascual, et al.. (2010). Effect of addition of rituximab to salvage chemotherapy on outcome of patients with diffuse large B-cell lymphoma relapsing after an autologous stem-cell transplantation. Annals of Oncology. 21(9). 1891–1897. 9 indexed citations
12.
Brunet, Salut, Juan José Berlanga, Mar Tormo, et al.. (2008). CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapy. Leukemia. 23(3). 486–491. 46 indexed citations
13.
Pérez-Simón, Josè Antonio, Rodrigo Martino, Dolores Caballero, et al.. (2008). Reduced-Intensity Conditioning Allogeneic Transplantation from Unrelated Donors: Evaluation of Mycophenolate Mofetil Plus Cyclosporin A as Graft-versus-Host Disease Prophylaxis. Biology of Blood and Marrow Transplantation. 14(6). 664–671. 19 indexed citations
14.
Hernández‐Espinosa, David, Antonia Miñano, Constantino Martı́nez, et al.. (2006). l-Asparaginase-Induced Antithrombin Type I Deficiency. American Journal Of Pathology. 169(1). 142–153. 42 indexed citations
15.
Ortuño, Francisco José & Inmaculada Heras. (2005). Coagulase-Negative Staphylococcus within Neutrophils in Acute Leukemia. New England Journal of Medicine. 353(8). e7–e7. 2 indexed citations
16.
Arriba, Felipe de, Javier Corral, Francisco Ayala, et al.. (1999). Autoaggression syndrome resembling acute graft-versus-host disease grade IV after autologous peripheral blood stem cell transplantation for breast cancer. Bone Marrow Transplantation. 23(6). 621–624. 18 indexed citations
17.
Ortuño, Francisco José, et al.. (1998). Bone marrow steady-state CD34+/CD71− cell content is a predictive value of rG-CSF-mobilized CD34+ cells. Bone Marrow Transplantation. 21(10). 983–985. 4 indexed citations
18.
Corral, Javier, Rocío Gónzález‐Conejero, Marı́a Luisa Lozano, et al.. (1997). The venous thrombosis risk factor 20210 A allele of the prothrombin gene is not a major risk factor for arterial thrombotic disease. British Journal of Haematology. 99(2). 304–307. 77 indexed citations
19.
Ortuño, Francisco José, José M. Moraleda, Marı́a Luisa Lozano, et al.. (1996). Immune recovery after autologous or rhG‐CSF primed PBSC transplantation. European Journal Of Haematology. 56(5). 301–307. 22 indexed citations
20.
Lozano, Marı́a Luisa, Francisco José Ortuño, Felipe de Arriba, et al.. (1995). Effect of rhG-CSF on the mobilization of CD38 and HLA-DR subfractions of CD34+ peripheral blood progenitor cells. Annals of Hematology. 71(3). 105–110. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keiko Yumura‐Yagi Breakdown of academic impact, for papers by Alexey Maschan Breakdown of academic impact, for papers by Yukiko Tsunematsu Breakdown of academic impact, for papers by Reggie Duerst Breakdown of academic impact, for papers by John Moppett Breakdown of academic impact, for papers by Masaaki Kumagai Breakdown of academic impact, for papers by Guillermo Debén Breakdown of academic impact, for papers by Roberta H. Adams Breakdown of academic impact, for papers by Massimiliano Postorino Breakdown of academic impact, for papers by Yasunori Ueda
Rankless by CCL
2026